Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

H William Rastetter

Affiliations

  • Director at Fate Therapeutics Inc (FATE), 2016-11-28
  • Director at Cerulean Pharma Inc. (CERU), 2016-10-20
  • Director at Regulus Therapeutics Inc. (RGLS), 2016-06-03
  • Director at Neurocrine Biosciences Inc (NBIX), 2016-05-24
  • Director at Illumina Inc (ILMN), 2016-01-04
  • Director at Receptos Inc. (RCPT), 2015-08-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
FATE $2.66 375,939 Director 459,272 2016-11-23 Filing
RGLS $10.19 61,235 Director 100,000 2015-07-21 Filing
RGLS $10.13 38,765 Director 38,765 2015-07-20 Filing
CERU $7.00 18,869 Director 60,307 2014-04-15 Filing
FATE $6.00 83,333 Director 83,333 2013-10-04 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ILMN $195.52 200 Director 5,953 2015-01-20 Filing
ILMN $194.91 3,683 Director 6,153 2015-01-20 Filing
ILMN $193.88 907 Director 9,836 2015-01-20 Filing
ILMN $192.60 543 Director 10,743 2015-01-20 Filing
ILMN $191.09 600 Director 11,286 2015-01-20 Filing